Page last updated: 2024-08-24

cephalosporin c and Respiratory Syndrome, Acute, Severe

cephalosporin c has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abril-Pérez, C; Botella-Estrada, R; Roca-Ginés, J; Sánchez-Arráez, J; Torres-Navarro, I1

Other Studies

1 other study(ies) available for cephalosporin c and Respiratory Syndrome, Acute, Severe

ArticleYear
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:10

    Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome

2020